Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein

被引:122
作者
Alhadi, HA [1 ]
Fox, KAA [1 ]
机构
[1] Univ Edinburgh, Royal Infirm Edinburgh, Ctr Cardiovasc Sci, Cardiovasc Res Unit, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1093/qjmed/hch037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart fatty-acid-binding protein (FABP) is a small cytosolic protein that is abundant in the heart and has low concentrations in the blood and in tissues outside the heart. It appears in the blood as early as 1.5 h after onset of symptoms of infarction, peaks around 6 h and returns to baseline values in 24 h. These features of H-FABP make it an excellent potential candidate for the detection of acute myocardial infarction (AMI). We review the strengths and weaknesses of H-FABP as a clinically applicable marker of myocyte necrosis in the context of acute coronary syndromes.
引用
收藏
页码:187 / 198
页数:12
相关论文
共 126 条
  • [1] ABE S, 1991, CIRCULATION, V84, P291
  • [2] URINARY MYOGLOBIN IN MYOCARDIAL INFARCTION
    ADAMS, EC
    ELLIOTT, TA
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 211 (06) : 1013 - +
  • [3] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [4] ANDERSON HV, 1993, NEW ENGL J MED, V329, P703
  • [5] Cloning and sequencing of complementary DNA for fatty acid binding protein from rainbow trout heart
    Ando, S
    Xu, XH
    Tibbits, GF
    Haunerland, NH
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1998, 119 (01): : 213 - 217
  • [6] [Anonymous], 1988, LANCET, V2, P349
  • [7] [Anonymous], 1986, Lancet, V1, P397
  • [8] Heparin in acute coronary disease - Requiem for a heavyweight?
    Armstrong, PW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) : 492 - 494
  • [9] FAILURE OF NEW BIOCHEMICAL MARKERS TO EXCLUDE ACUTE MYOCARDIAL-INFARCTION AT ADMISSION
    BAKKER, AJ
    KOELEMAY, MJW
    GORGELS, JPMC
    VANVLIES, B
    SMITS, R
    TIJSSEN, JGP
    HAAGEN, FDM
    [J]. LANCET, 1993, 342 (8881) : 1220 - 1222
  • [10] AFTER CORONARY THROMBOLYSIS AND REPERFUSION, WHAT NEXT
    BANG, NU
    WILHELM, OG
    CLAYMAN, MD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (04) : 837 - 849